European Urology Focus Урология

ARALU - Phase 2, Open-label, Randomized Study to Investigate Safety and Efficacy of Pluvicto Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer in Addition to Standard of Care Treatment with Nubeqa and ADT

Elsevier ·

Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.

Читать у издателя →